Overview of Daiichi Sankyo - Daiichi Sankyo is a global pharmaceutical company headquartered in Tokyo, Japan [4] - For the fiscal year ending March 31, 2026, the company expects revenue of approximately JPY 2.1 trillion, reflecting an 11% increase from the previous fiscal year [4] ADC Technology - The company is focusing on its ADCs, particularly the DXd-ADC technology, which is a key driver of growth [3] - ENHERTU and DATROWAY are highlighted as significant products contributing to this growth [3] Science and Technology Strategy - Daiichi Sankyo is implementing a new multi-modality strategy in its science and technology initiatives [3] Shareholder Return Policy - The company emphasizes a strong commitment to enhancing shareholder value through its return policy [3]